KeyBanc reiterates Overweight on CAVA stock ahead of earnings By Investing.com

CAVA shares are down roughly 15% over the past five days ahead of Q1 earnings on May 19, with consensus calling for 6.1% comparable sales growth. KeyBanc kept an Overweight rating but flagged that expectations remain above Street estimates in the high single digits, while focus shifts to quarter-to-date momentum and 2026 same-restaurant sales guidance of 3.0% to 5.0%. Options activity is elevated, with 12,925 contracts traded, including 7,482 calls and 5,443 puts.

Analysis

The setup is less about the headline guidance and more about positioning into a crowded print where expectations have drifted above published estimates. That creates asymmetric event risk: a small miss on same-store sales or a cautious quarter-to-date commentary can produce a disproportionate de-rating because the stock still trades like a durable growth compounder rather than a consumer discretionary name with macro sensitivity.

The second-order issue is peer contagion. Fast-casual weakness tends to compress the entire basket first and only later discriminate on unit economics, so a clean CAVA print may still be sold if the market wants to de-risk restaurant multiples broadly. Conversely, if CAVA re-accelerates traffic, it can temporarily re-open the premium growth trade and force short covering across higher-multiple consumer names that share the same “growth at any price” holder base.

The biggest contrarian point is that the market may be underestimating how much of the recent move is mechanical rather than fundamental. Elevated options activity suggests implied volatility may still be cheap relative to the probability distribution of an earnings gap, but the direction is not obvious: strong numbers may only recover a portion of the prior drawdown if guidance stays conservative, while a modest miss could trigger a much larger air pocket. The key variable is not the quarter itself but whether management changes the path to the 2026 outlook from “defendable” to “accelerating,” which would matter more for valuation than a one-quarter comp beat.

From a risk standpoint, the downside is concentrated over the next 24-72 hours, while the upside case unfolds over several months if management proves the growth algorithm is intact. If the company reiterates 2026 targets without tightening the range, the stock likely remains range-bound and vulnerable to multiple compression; if it raises confidence on traffic and ticket, the market can quickly re-rate the name because the premium multiple leaves little room for lingering doubt.

Key Decisions for Investors

• Buy a short-dated straddle in CAVA into the print; the setup favors a move larger than implied vol because positioning is crowded and the valuation leaves little cushion for a miss or a muted guide.
• If already long CAVA, reduce pre-earnings exposure by 25-50% and re-add only on confirmation of quarter-to-date momentum; the risk/reward is skewed toward protecting capital rather than chasing upside at 147x earnings.
• Relative-value trade: long CAVA / short a fast-casual peer basket for 1-4 weeks only if the thesis is clean outperformance on traffic; otherwise avoid outright longs because peer multiple compression can cap the move.
• For hedgers, buy out-of-the-money CAVA puts one to two expiries out instead of selling the stock outright; this preserves upside if management surprises positively while protecting against a sharp de-rating on a small miss.
• If the stock sells off on a merely in-line print, look to buy the post-earnings dip only after the first 1-2 sessions of price discovery; the trade works best if the guide remains intact and the market overreacts mechanically to headline comps.